Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis

Helen F Galley

Research output: Contribution to journalLiterature reviewpeer-review

119 Citations (Scopus)
8 Downloads (Pure)


Development of organ dysfunction associated with sepsis is now accepted to be due at least in part to oxidative damage to mitochondria. Under normal circumstances, complex interacting antioxidant defense systems control oxidative stress within mitochondria. However, no studies have yet provided conclusive evidence of the beneficial effect of antioxidant supplementation in patients with sepsis. This may be because the antioxidants are not accumulating in the mitochondria, where they are most needed. Antioxidants can be targeted selectively to mitochondria by several means. This review describes the in vitro studies and animal models of several diseases involving oxidative stress, including sepsis, in which antioxidants targeted at mitochondria have shown promise, and the future implications for such approaches in patients.
Original languageEnglish
Article number230
Number of pages9
JournalCritical Care
Issue number4
Publication statusPublished - 20 Aug 2010


Dive into the research topics of 'Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis'. Together they form a unique fingerprint.

Cite this